GC Biopharma announced that it has signed a contract for the processing of plasma derivatives with Solid Intellectual SDN BHD (SISB), a subsidiary of the Malaysian JAKEL Group.
News & Resources
| [Jun02] GC Biopharma signs plasma processing contract with Malaysian firm SISB | |||
| Name | KPBMA | ||
|---|---|---|---|
| Registration date | 2025/06/04 | ||
| Links(files, etc.) | |||
|
|
|||
| Prev | [May30] Yuhan Corporation secures 20.7 billion won for Leclaza commercialization in Japan | ||
| Next | [Jun02] EuBiologics wins WHO PQ for second oral cholera vaccine plant | ||